Positive and negative regulation of prostate Stem Cell Antigen expression by Yin Yang 1 in Prostate epithelial Cell lines

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Tang, Shuai ^a   Mishra, Meenu ^a,b   Frazier, Donna P ^a   Moore, Miranda L ^a   Inoue, Kazushi ^a   Deora, Rajendar ^a   Sui, Guangchao ^a   Dubey, Purnima ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PROSTATE STEM CELL ANTIGEN; TRANSCRIPTION FACTOR YY1; ANDROGEN RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; POLYNUCLEOTIDE; PSCA PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE SEVERITY; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NEGATIVE REGULATION; POSITIVE REGULATION; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; CELL LINE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CYTOLOGY; DNA RESPONSIVE ELEMENT; EPITHELIUM CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PROSTATE; SITE DIRECTED MUTAGENESIS;

ANIMALS; ANTIGENS, NEOPLASM; BASE SEQUENCE; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GPI-LINKED PROTEINS; HUMANS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; POLYNUCLEOTIDES; PROMOTER REGIONS, GENETIC; PROSTATE; PROTEIN BINDING; RECEPTORS, ANDROGEN; RESPONSE ELEMENTS; YY1 TRANSCRIPTION FACTOR;

EID: 84859880568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035570     Document Type: Article

References (39)

1. Backman SA, Ghazarian D, So K, Sanchez O, Wagner KU, et al. (2004) Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci U S A 101: 1725-1730.
2. Kibel AS, Schutte M, Kern SE, Isaacs WB, Bova GS, (1998) Identification of 12p as a region of frequent deletion in advanced prostate cancer. Cancer Res 58: 5652-5655.
3. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, et al. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209-221.
4. Dobosy JR, Roberts JL, Fu VX, Jarrard DF, (2007) The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 177: 822-831.
5. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, et al. (1998) Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A 95: 1735-1740.
6. Tran CP, Lin C, Yamashiro J, Reiter RE, (2002) Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 1: 113-121.
7. Ross S, Spencer SD, Lasky LA, Koeppen H, (2001) Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis. Am J Pathol 158: 809-816.
8. Ross S, Spencer SD, Holcomb I, Tan C, Hongo J, et al. (2002) Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate. Cancer Res 62: 2546-2553.
9. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, et al. (2001) Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci U S A 98: 2658-2663.
10. Lepin EJ, Leyton JV, Zhou Y, Olafsen T, Salazar FB, et al. (2010) An affinity matured minibody for PET imaging of prostate stem cell antigen (PSCA)-expressing tumors. Eur J Nucl Med Mol Imaging 37: 1529-1538.
11. Zhigang Z, Wenlu S, (2007) Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer. Prostate 67: 1143-1151.
12. Moore ML, Teitell MA, Kim Y, Watabe T, Reiter RE, et al. (2008) Deletion of PSCA increases metastasis of TRAMP-induced prostate tumors without altering primary tumor formation. Prostate 68: 139-151.
13. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE, (2002) Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol 16: 2323-2337.
14. Shi Y, Lee JS, Galvin KM, (1997) Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1332: F49-66.
15. Deng Z, Cao P, Wan M, Sui G, (2010) Yin Yang 1: A multifaceted protein beyond a transcription factor. Transcr 1: 81-84.
16. Castellano G, Torrisi E, Ligresti G, Malaponte G, Militello L, et al. (2009) The involvement of the transcription factor Yin Yang 1 in cancer development and progression. Cell Cycle 8: 1367-1372.
17. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R, (2004) Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 6: 744-750.
18. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, et al. (2005) Expression of transcription factor Yin Yang 1 in prostate cancer. Int J Oncol 27: 131-141.
19. Deng Z, Wan M, Cao P, Rao A, Cramer SD, et al. (2009) Yin Yang 1 regulates the transcriptional activity of androgen receptor. Oncogene 28: 3746-3757.
20. Jiao J, Wang S, Qiao R, Vivanco I, Watson PA, et al. (2007) Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development. Cancer Res 67: 6083-6091.
21. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818.
22. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW, (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
23. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
24. Hirai H, Sherr CJ, (1996) Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 16: 6457-6467.
25. Deora R, Bootsma HJ, Miller JF, Cotter PA, (2001) Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene. Mol Microbiol 40: 669-683.
26. Mishra M, Deora R, (2005) Mode of action of the Bordetella BvgA protein: transcriptional activation and repression of the Bordetella bronchiseptica bipA promoter. J Bacteriol 187: 6290-6299.
27. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K, (2005) Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol 25: 220-232.
28. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367.
29. Watabe T, Lin M, Ide H, Donjacour AA, Cunha GR, et al. (2002) Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc Natl Acad Sci U S A 99: 401-406.
30. Hyde-DeRuyscher RP, Jennings E, Shenk T, (1995) DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res 23: 4457-4465.
31. Gordon S, Akopyan G, Garban H, Bonavida B, (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25: 1125-1142.
32. Thomas MJ, Seto E, (1999) Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236: 197-208.
33. Deng Z, Wan M, Sui G, (2007) PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger. Mol Cell Biol 27: 3780-3792.
34. Dubey P, Wu H, Reiter RE, Witte ON, (2001) Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression. Cancer Res 61: 3256-3261.
35. Lieberthal JG, Kaminsky M, Parkhurst CN, Tanese N, (2009) The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells. Breast Cancer Res 11: R42.
36. Tan DP, Nonaka K, Nuckolls GH, Liu YH, Maxson RE, et al. (2002) YY1 activates Msx2 gene independent of bone morphogenetic protein signaling. Nucleic Acids Res 30: 1213-1223.
37. Bahrenberg G, Brauers A, Joost HG, Jakse G, (2001) PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112. Cancer Lett 168: 37-43.
38. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, et al. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41: 991-995.
39. Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, et al. (2008) Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 40: 730-740.